In terms of metabolic endpoints, Gonzalez et al. [10] found an inverse association between obesity and ANA positivity in women (but none in men), and Heras et al. [11] observed higher ANA positivity among individuals with type 1 diabetes than among nondiabetic individuals. Here, BTG3 is linked to obesity due to melanocortin 4 receptor deficiency.